We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Getein Biotech, Inc.

Getein Biotech, Inc. is a fully integrated in vitro diagnostic company that develops, manufactures and distributes an... read more Featured Products: More products

Download Mobile App





Getein Biotech Showcases Latest POCT Analyzers

By LabMedica International staff writers
Posted on 13 Nov 2024

Getein Biotech, Inc. More...

(Nanjing, China) is showcasing its latest IVD and POCT solutions at MEDICA 2024.

At this year’s MEDICA, Getein Biotech is presenting the MAGICL 6000 compact and innovative chemiluminescence immunoassay analyzer designed for mid to high-workflow laboratories that need a one-step chemiluminescence solution. Highly productive and compact, this instrument enables fully automated operation and provides the fastest testing speed of any device of its size. Alongside, Getein is highlighting the Getein 1200 immunofluorescence quantitative analyzer, a truly automated, modular, intelligent and dry system. The instrument has a low failure rate and moderate measurement speed, which is convenient for clinical departments with medium and high throughput use. Visitors to the Getein booth can also experience the Getein 1160 immunofluorescence quantitative analyzer which has four incubation channels and one emergency test channel, and a constant test environment with 32℃ to ensure more accurate test results.

Among its molecular diagnostic solutions, Getein is presenting the GN 7000 Akso PCR system, a compact and fully automated PCR lab that integrates nucleic acid release, PCR amplification, real-time detection, and result analysis to offer a one-step POCT solution for nucleic acid detection. Getein is also showcasing the Metis 6000 integrated clinical chemistry and immunochemistry modular system which is independently developed and produced. Metis 6000 integrates the MAGICL 6200 immunochemistry module (stand-alone 400 T/h) and CM-1000 clinical chemistry module (stand-alone constant speed 1000 T/h, ISE 400 T/h), and is equipped with the SH 80 sample supply track unit and SHC 200 automatic pre-analytical system. The dual module requires only 2.6m2 of space and provides customers with a more cost-effective menu of more than 180 self-generated chemistries and immunological reagents, which can be widely used in laboratories with different throughputs.

Among its range of diagnostic tests, Getein is showcasing the One Step Test for D-Dimer (Colloidal Gold) which is used as an aid in the assessment and exclusion of suspected deep vein thrombosis (DVT) or pulmonary embolism (PE) in the physical department or emergency room (ER). Additionally, the company is highlighting the Getein Cardiac Troponin l Fast Test Kit (Colloidal Gold) which is intended for the in vitro qualitative and semi-quantitative determination of cardiac Troponin l (cTnl) in serum, plasma or whole blood.

Related Links:
Getein Biotech, Inc.


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Respiratory Infections Test
STANDARD Q Adeno Respi Ag Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.